By analyzing the reported adverse events in the US Food and Drug Administrations database, Elashoff reported that treatment with DPP4 inhibitor sitagliptin or GLP-1R agonist exenatide increased the risk of pancreatitis and pancreatic cancer as compared with other therapies
Fatigue significant
"Addressing even one crore patients translates to a Rs 3,0004,000 crore opportunity," he says, "but the market will only expand meaningfully at lower price points, especially beyond metros." He expects the GLP-1 category to surpass Rs 2,000 crore within a year, led by generics driving down entry barriers
Recognizing Squamous Cell Carcinoma Squamous Cell Carcinoma (SCC) is the second most common form of skin cancer
A postpartum patient deserves a program thats going to walk alongside her, not just send a prescription to her doorstep. Hers Hers is one of the best programs for postpartum women, offering specialized plans that are convenient and effective, thanks to a psychologist-developed approach to weight loss
